St. Jude Medical, Inc. (NYSE:STJ) today announced it will display
products and technologies from the company’s wide array of clinical
solutions in the cardiology, cardiac surgery, atrial fibrillation and
cardiac rhythm management markets at ACC 2010.
“We offer a full range of products and technologies from across the
company designed to decrease hospitalizations, improve patient quality
of life and reduce healthcare costs.”
“St. Jude Medical is pleased to showcase our latest cardiac care
solutions, from technologies that help to better connect patients to
physicians, to devices proven to improve patient outcomes,” said Frank
Callaghan, president of the St. Jude Medical Cardiovascular Division.
“We offer a full range of products and technologies from across the
company designed to decrease hospitalizations, improve patient quality
of life and reduce healthcare costs.”
Products and technologies will be on display at St. Jude Medical booth
718 during the American College of Cardiology (ACC) Conference at the
Georgia World Congress Center on Sunday, March 14, 9 a.m. - 4:30 p.m.,
Monday, March 15, 9 a.m. - 4:30 p.m. and Tuesday, March 16, 9 a.m. - 1
p.m., including:
Cardiovascular Division
-
Engage™ Family of Introducers:
This new product line was designed to provide physicians with reliable
access and set the stage for closure using the Angio-Seal™
device. The Engage™ Introducer is used for femoral access, in which
physicians access the patient’s heart through the femoral vein or
artery located near the groin. The Engage TR™ Introducer portfolio
expands the company’s product offering to include introducers used for
radial access, in which physicians access the patient’s heart through
the radial artery in the arm. The Engage Introducers have received FDA
clearance and CE Mark approval.
-
PressureWire™ technology: The
landmark FAME (Fractional Flow
Reserve (FFR) vs. Angiography in Multivessel
Evaluation) study compared
FFR-guided treatment using a St. Jude Medical PressureWire to
treatment using standard angiography alone, and found both superior
clinical outcomes and reduced healthcare costs in patients whose
treatment was based on FFR. The next generation of PressureWire™
Certus is the only guidewire on the market to offer in one wire
the combined measurement of pressure and temperature which enables
calculations of FFR, Coronary Flow Reserve (CFR) and an Index of
Microcirculatory Resistance (IMR). The PressureWire™
Aeris is a first-of-its-kind wireless FFR measuring system
requiring no additional equipment or cabling and gives physicians
instant access to patient data; it can be used with multiple recording
systems including the GE Mac-Lab® Hemodynamic Recording System, Mennen
Horizon XVu and the McKesson Horizon Cardiology Hemo™ solution. Both
products have FDA clearance and CE Mark approval.
-
Other Interventional Cardiology and
Cardiac Surgery Products on Display: Epic™ Stented Tissue
Valves with Linx AC Technology, Biocor™ Stented Tissue Valves, Attune™
Flexible Adjustable Annuloplasty Ring, and Regent™ Mechanical Heart
Valve.
Atrial Fibrillation Division